Profile | GDS4284 / 203595_s_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 2192.89 | 85 |
GSM687648 | Patient 402 control | 1855.03 | 83 |
GSM687653 | Patient 403 control | 2656.99 | 87 |
GSM687658 | Patient 404 control | 2949.1 | 88 |
GSM687663 | Patient 411 control | 1466.32 | 80 |
GSM687668 | Patient 422 control | 2004.54 | 84 |
GSM687673 | Patient 424 control | 2129.04 | 85 |
GSM687678 | Patient 425 control | 1414.41 | 79 |
GSM687683 | Patient 427 control | 2082.23 | 84 |
GSM687688 | Patient 428 control | 1663.53 | 81 |
GSM687695 | Patient 441 control | 3605.22 | 91 |
GSM687699 | Patient 443 control | 1812.88 | 83 |
GSM687704 | Patient 444 control | 2307.66 | 86 |
GSM687707 | Patient 448 control | 2686.72 | 88 |
GSM687712 | Patient 449 control | 2773.2 | 88 |
GSM687719 | Patient 450 control | 2320.15 | 86 |
GSM687724 | Patient 451 control | 2999.51 | 89 |
GSM687728 | Patient 452 control | 2435.76 | 86 |
GSM687646 | Patient 401 treated 24h | 1544.48 | 80 |
GSM687649 | Patient 402 treated 24h | 1997.01 | 83 |
GSM687665 | Patient 411 treated 24h | 1458.76 | 80 |
GSM687651 | Patient 402 treated 4 weeks | 1976.91 | 84 |
GSM687667 | Patient 411 treated 4 weeks | 1247.65 | 77 |
GSM687670 | Patient 422 treated 24h | 1938.28 | 83 |
GSM687671 | Patient 422 treated 4 weeks | 1894.52 | 83 |
GSM687654 | Patient 403 treated 24h | 3190.09 | 89 |
GSM687675 | Patient 424 treated 24h | 1926.24 | 84 |
GSM687685 | Patient 427 treated 24h | 1881.71 | 83 |
GSM687656 | Patient 403 treated 4 weeks | 2085.61 | 84 |
GSM687677 | Patient 424 treated 4 weeks | 2227.47 | 85 |
GSM687687 | Patient 427 treated 4 weeks | 1984.87 | 83 |
GSM687692 | Patient 428 treated 4h | 2538.67 | 87 |
GSM687716 | Patient 449 treated 4h | 2313.45 | 86 |
GSM687722 | Patient 450 treated 4h | 2790.58 | 88 |
GSM687680 | Patient 425 treated 24h | 1610.42 | 81 |
GSM687690 | Patient 428 treated 24h | 2283.73 | 86 |
GSM687700 | Patient 443 treated 24h | 1952.96 | 84 |
GSM687705 | Patient 444 treated 24h | 2953.75 | 88 |
GSM687714 | Patient 449 treated 24h | 2800.2 | 88 |
GSM687721 | Patient 450 treated 24h | 2997.11 | 89 |
GSM687682 | Patient 425 treated 4 weeks | 2017.66 | 84 |
GSM687694 | Patient 428 treated 4 weeks | 1906.81 | 83 |
GSM687702 | Patient 443 treated 4 weeks | 1590.35 | 81 |
GSM687718 | Patient 449 treated 4 weeks | 2421.15 | 86 |
GSM687723 | Patient 450 treated 4 weeks | 2315.73 | 86 |
GSM687661 | Patient 404 treated 4h | 2975.16 | 89 |
GSM687710 | Patient 448 treated 4h | 2661.55 | 87 |
GSM687726 | Patient 451 treated 4h | 3311.24 | 90 |
GSM687730 | Patient 452 treated 4h | 1432.31 | 80 |
GSM687660 | Patient 404 treated 24h | 13144.2 | 97 |
GSM687697 | Patient 441 treated 24h | 3468.54 | 91 |
GSM687709 | Patient 448 treated 24h | 2604.83 | 87 |
GSM687725 | Patient 451 treated 24h | 5294.54 | 94 |
GSM687729 | Patient 452 treated 24h | 2626.11 | 88 |
GSM687727 | Patient 451 treated 4 weeks | 3377.42 | 90 |
GSM687731 | Patient 452 treated 4 weeks | 5116.17 | 94 |